Balanced Salt Solution for Cataract Surgery
What You Need to Know Before You Apply
What is the purpose of this trial?
This study aims to identify if the use of BSS PLUS® Sterile Intraocular Irrigating Solution as an irrigation solution leads to improved corneal outcomes vs BSS® Sterile Irrigating Solution in more compromised corneas.
Are You a Good Fit for This Trial?
This trial is for adults over 22 with bilateral visually significant cataracts and Fuchs' Dystrophy, which affects the cornea. Participants should be generally healthy but can have controlled diabetes or hypertension. They must understand and sign consent, attend all post-op visits, and if female of childbearing age, use birth control during the study.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo cataract surgery using either BSS PLUS® or BSS® Sterile Irrigating Solution
Follow-up
Participants are monitored for corneal outcomes and other ocular measures post-surgery
What Are the Treatments Tested in This Trial?
Interventions
- BSS
- BSS Plus
Find a Clinic Near You
Who Is Running the Clinical Trial?
Adam Fedyk, MD, FACS
Lead Sponsor
Alcon Research
Industry Sponsor
Raquel C. Bono
Alcon Research
Chief Medical Officer since 2022
MD from Harvard Medical School
David Endicott
Alcon Research
Chief Executive Officer since 2018
MBA from University of Southern California